Banco Santander S.A. (SAN)
14.93
-0.12 (0.80%)
Upcoming Events
Latest Headlines
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR14.70 at Morgan Stanley
September 2, 2026 5:09 AM - StreetInsider
Form CERT Banco Santander, S.A.
August 27, 2026 9:37 AM - SEC Filing
Form 8-A12B Banco Santander, S.A.
August 27, 2026 9:04 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Aug 27
August 27, 2026 6:08 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR14.10 at Citi
August 27, 2026 4:23 AM - StreetInsider
Increasing unusual call option volume: CG ETH SAN PSNL XP UCTT DUOT CRK AGEN
August 25, 2026 6:28 AM - StreetInsider
Form N-PX Sanofi For: Jun 30
August 25, 2026 6:06 AM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Jun 30
August 20, 2026 4:34 PM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Aug 19
August 20, 2026 11:58 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Aug 20
August 20, 2026 6:05 AM - SEC Filing
Santander Expands U.S. Presence with Completion of Webster Acquisition
August 20, 2026 3:34 AM - BizWire
Form 424B5 Banco Santander, S.A.
August 18, 2026 8:22 AM - SEC Filing
Reddit Set to Join S&P 500 and Sun Communities to Join S&P MidCap 400
August 13, 2026 6:13 PM - PR NewsWire
Form 6-K BANCO SANTANDER CHILE For: Jul 31
August 12, 2026 5:00 PM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Aug 11
August 12, 2026 12:09 PM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Aug 07
August 11, 2026 12:58 PM - SEC Filing
Middle-Income Americans Value In-Person Support for Major Financial Decisions, Santander US Survey Finds
August 11, 2026 10:05 AM - BizWire
Form 6-K Banco Santander, S.A. For: Aug 10
August 10, 2026 12:26 PM - SEC Filing
Form 6-K Santander UK plc For: Jun 30
August 7, 2026 10:56 AM - SEC Filing
Trump Administration Weighs Order On Autism And Vaccines - Bloomberg
August 6, 2026 4:36 PM - StreetInsider
Form 6-K Banco Santander, S.A. For: Aug 06
August 6, 2026 6:09 AM - SEC Filing
Form 6-K Sanofi For: Aug 06
August 6, 2026 6:08 AM - SEC Filing
Press Release: Sanofi’s half-year financial report for 2026
July 30, 2026 9:38 AM - Globe NewsWire
Banco Santander (SAN) PT Lowered to $6 at JPMorgan
July 30, 2026 9:19 AM - StreetInsider
Form 6-K Sanofi For: Jun 30
July 30, 2026 7:34 AM - SEC Filing
Form 6-K Sanofi For: Jun 30
July 30, 2026 6:29 AM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Jun 30
July 29, 2026 11:23 AM - SEC Filing
Form 13F-HR Banco Santander, S.A. For: Jun 30
July 29, 2026 6:19 AM - SEC Filing
Form 13F-HR Sanofi For: Jun 30
July 28, 2026 6:15 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR13.50 at RBC Capital
July 28, 2026 5:36 AM - StreetInsider
Form 6-K Sanofi For: Jul 27
July 27, 2026 6:10 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR13.55 at Deutsche Bank
July 27, 2026 4:49 AM - StreetInsider
Form 6-K Banco Santander, S.A. For: Jun 30
July 24, 2026 7:42 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Jun 30
July 24, 2026 6:37 AM - SEC Filing
Form 6-K Santander UK plc For: Jul 23
July 23, 2026 12:46 PM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR14 at Barclays
July 23, 2026 5:06 AM - StreetInsider
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR13.80 at Morgan Stanley
July 23, 2026 4:37 AM - StreetInsider
Form SCHEDULE 13G/A Sanofi Filed by: Amundi
July 22, 2026 9:50 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Jun 30
July 22, 2026 6:11 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Jun 30
July 22, 2026 6:07 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Jun 30
July 22, 2026 6:05 AM - SEC Filing
Form 6-K SEABRIDGE GOLD INC For: Jul 21
July 22, 2026 6:02 AM - SEC Filing
Banco Santander S.A. (SAN) Reports Q2 EPS of EUR0.25
July 22, 2026 2:16 AM - StreetInsider
Sanofi reshapes executive committee effective September 2026
July 21, 2026 12:05 PM - StreetInsider
Press Release: Sanofi evolves its Executive Committee to support its next strategic chapter
July 21, 2026 12:00 PM - Globe NewsWire
Form 6-K SEABRIDGE GOLD INC For: Jul 20
July 20, 2026 10:49 AM - SEC Filing
Form 6-K Sanofi For: Jul 17
July 17, 2026 6:04 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Jul 16
July 16, 2026 6:25 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR13.70 at Barclays
July 14, 2026 4:51 AM - StreetInsider
Form 6-K BANCO SANTANDER CHILE For: Jun 30
July 10, 2026 5:17 PM - SEC Filing
Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
July 10, 2026 8:35 AM - Globe NewsWire
Form 6-K BANCO SANTANDER CHILE For: Jul 08
July 8, 2026 4:20 PM - SEC Filing
Form 6-K Sanofi For: Jul 07
July 7, 2026 9:02 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Jul 02
July 2, 2026 6:17 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR13.50 at Morgan Stanley
July 2, 2026 4:35 AM - StreetInsider
Form 11-K Sanofi For: Dec 31
June 30, 2026 1:28 PM - SEC Filing
Form 11-K Sanofi For: Dec 31
June 30, 2026 12:54 PM - SEC Filing
Form NT 11-K Sanofi For: Dec 31
June 30, 2026 11:49 AM - SEC Filing
Form NT 11-K Sanofi For: Dec 31
June 30, 2026 11:45 AM - SEC Filing
Form 6-K BANCO SANTANDER CHILE For: Jun 24
June 24, 2026 4:20 PM - SEC Filing
Banco Santander Chile: Second Quarter 2026 Analyst and Investor Webcast / Conference Call
June 24, 2026 10:57 AM - Globe NewsWire
Form 6-K Sanofi For: Jun 24
June 24, 2026 8:44 AM - SEC Filing
Banco Santander SA (SAN:SM) (SAN) PT Raised to EUR13.45 at Citi
June 23, 2026 5:03 AM - StreetInsider
Form 6-K Sanofi For: Jun 22
June 22, 2026 8:43 AM - SEC Filing
Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D
June 22, 2026 2:00 AM - Globe NewsWire
Sanofi wins Japan approval for Sarclisa SC in multiple myeloma
June 19, 2026 6:31 AM - StreetInsider
Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
June 19, 2026 6:31 AM - Globe NewsWire
Form 6-K Banco Santander, S.A. For: Jun 18
June 18, 2026 6:17 AM - SEC Filing
Why does Barclays say it’s time to buy this Spanish stock?
June 13, 2026 4:00 AM - StreetInsider
Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
June 12, 2026 6:10 PM - Globe NewsWire
Form 6-K BANCO SANTANDER CHILE For: May 31
June 12, 2026 1:36 PM - SEC Filing
Form 6-K Sanofi For: Jun 12
June 12, 2026 11:42 AM - SEC Filing
Form 6-K Banco Santander, S.A. For: Jun 10
June 10, 2026 6:08 AM - SEC Filing
Form SC TO-I/A Banco Santander, S.A. Filed by: Banco Santander, S.A.
June 10, 2026 6:04 AM - SEC Filing
Form 6-K Sanofi For: Jun 08
June 8, 2026 6:07 AM - SEC Filing
Full Article List